This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


reputable news agency


Eli Lilly warns that two insulin products will be in short supply

Eli lilly warns that 2 insulin products will be in short supply

Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products.

"The 10 mL [millilter] vials of Humalog and Insulin Lispro Injection are or will be temporarily out of stock at wholesalers and some pharmacies through the beginning of April," Lilly said in a recent statement.

The company said it is continuing to make the 10 mL vials, and "will ship them as soon as we can." However, in the meantime patients with diabetes may need to consult with their doctors "to discuss switching to the same insulin in a prefilled pen or other insulin treatment options," Lilly said.

Switching to another product may be more easily said than done, noted patient advocate Laura Marston. She has type 1 and uses Humalog.

Marston told CNN that she uses the vials in her insulin pump. Her only covers the vials, through a prior authorization process that may be tough to get around.

"If Lilly doesn't fix this fast, I actually don't know what I'm going to do," Marston told CNN.

Lilly said it is offering customers without insurance a coupon program offering insulin for $35.

"We recognize that any supply challenge may cause a disruption in people's treatment regimens, and we are moving with urgency to address it," its statement said.

"Patients who need insulin immediately and cannot access their for an alternative treatment option should seek ," the company added.

Lilly spokesman Tarsis Lopez told CNN that the "dynamic nature of supply and demand, coupled with a brief delay in manufacturing, led to the temporary supply constraint."

More information: Find out more about insulin at the American Diabetes Association.

Copyright © 2024 HealthDay. All rights reserved.

Citation: Eli Lilly warns that two insulin products will be in short supply (2024, March 25) retrieved 16 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

More Americans will only have to pay $35 a month for insulin in 2024


Feedback to editors